667, L.P. is Director & 10% Owner at SEATTLE GENETICS INC /WA (SGEN). They have made 62 open-market trades across 13 companies since 2013, most recently 2025-06-30.
CIK 0001551139
45 open-market purchases totalling $1.3B since 2013, against 17 sales. Across 45 scored buys the stock is up 6.2% at ninety days, and 3.6 points ahead of the S&P over the same stretch.
45 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 64% | 60% | 64% |
| Avg Move | +0.2% | +2.3% | +6.2% |
| Alpha | -0.2% | +0.8% | +3.6% |
| Scored | 45 | 45 | 45 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 76% | 76% | 29% |
| Avg Move | -5.3% | -4.2% | +0.2% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMCR | BUY | 2025-03-17 | 2025-03-19 | $29.72 | $48.0M | +0.2% | -0.6% | +9.3% |
| KYMR | BUY | 2024-08-20 | 2024-08-22 | $46.41 | $46 | -0.7% | +7.5% | -5.2% |
| MDGL | BUY | 2023-12-12 | 2023-12-14 | $218.43 | $14.7M | +0.1% | +3.1% | +15.4% |
| ACAD | BUY | 2023-05-22 | 2023-05-24 | $25.33 | $45.4M | -7.7% | -5.7% | +11.9% |
| TCRX | BUY | 2022-05-10 | 2022-05-12 | $1.88 | $4.8M | +24.7% | +27.7% | +61.9% |
| IGMS | BUY | 2022-04-01 | 2022-04-05 | $23.00 | $65.0M | -20.0% | -25.2% | -16.7% |
| INCY | BUY | 2022-03-08 | 2022-03-10 | $72.24 | $56.1M | +4.8% | +8.6% | +0.6% |
| INCY | BUY | 2021-12-15 | 2021-12-17 | $72.43 | $229.0M | +0.5% | +1.7% | +0.8% |
| KOD | BUY | 2021-08-17 | 2021-08-19 | $87.50 | $19.9M | +7.4% | +14.0% | +16.5% |
| TCRX | BUY | 2021-07-20 | 2021-07-22 | $15.00 | $21.4M | +3.9% | +5.3% | -32.1% |
| NLTX | BUY | 2019-12-20 | 2019-12-20 | $8.40 | $27.4M | -2.3% | +0.1% | -35.1% |
| GHDX | SELL | 2019-01-25 | 2019-01-25 | $72.20 | $6.6M | +9.6% | +11.5% | -7.1% |
| GHDX | SELL | 2019-01-24 | 2019-01-25 | $72.02 | $5.7M | +9.6% | +11.5% | -7.1% |
| GHDX | SELL | 2019-01-23 | 2019-01-25 | $71.86 | $15.0M | +9.6% | +11.5% | -7.1% |
| GHDX | SELL | 2019-01-23 | 2019-01-25 | $70.65 | $2.6M | +9.6% | +11.5% | -7.1% |
| GHDX | SELL | 2018-12-12 | 2018-12-12 | $73.09 | $1.3M | -18.5% | -3.7% | +2.8% |
| GHDX | SELL | 2018-12-11 | 2018-12-12 | $74.08 | $4.1M | -18.5% | -3.7% | +2.8% |
| GHDX | SELL | 2018-12-10 | 2018-12-12 | $73.83 | $6.3M | -18.5% | -3.7% | +2.8% |
| GHDX | SELL | 2018-12-10 | 2018-12-12 | $73.83 | $657K | -18.5% | -3.7% | +2.8% |
| GHDX | SELL | 2018-11-27 | 2018-11-28 | $74.09 | $10.2M | -6.7% | -17.1% | +1.0% |
| GHDX | SELL | 2018-11-26 | 2018-11-28 | $74.13 | $13.1M | -6.7% | -17.1% | +1.0% |
| GHDX | SELL | 2018-11-26 | 2018-11-28 | $74.28 | $2.8M | -6.7% | -17.1% | +1.0% |
| GHDX | SELL | 2018-11-13 | 2018-11-13 | $79.69 | $9.0M | -2.4% | -8.1% | +5.7% |
| GHDX | SELL | 2018-11-13 | 2018-11-13 | $79.69 | $9.2M | -2.4% | -8.1% | +5.7% |
| GHDX | SELL | 2018-11-12 | 2018-11-13 | $80.38 | $1.1M | -2.4% | -8.1% | +5.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| ALXN | 509,726 | $93.0M |
| IMCR | 2,051,711 | $60.4M |
| NLTX | 3,107,331 | $43.4M |
| BCYC | 8,636,006 | $29.8M |
| BGNE | 93,413 | $17.3M |
| TCRX | 43,158,741 | $10.1M |
| SGEN | 23,280 | $5.3M |
| IDRA | 526,724 | $3.8M |
| XOMA | 90,538 | $3.7M |
| IGMS | 357,048 | $453K |
| VTVT | 8,060 | $223K |
| Total | $4.5B |
Shares reported on the most recent Form 4, priced at the 2025-07-02 close.
| Scored | 17 | 17 | 17 |